EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr | ₹105 Cr |
Adjustment | ₹543 Cr | ₹492 Cr | ₹399 Cr | ₹582 Cr | ₹611 Cr |
Changes In working Capital | ₹51 Cr | ₹-292 Cr | ₹-292 Cr | ₹-335 Cr | ₹-124 Cr |
Cash Flow after changes in Working Capital | ₹1,321 Cr | ₹947 Cr | ₹1,079 Cr | ₹905 Cr | ₹592 Cr |
Cash Flow from Operating Activities | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr | ₹500 Cr |
Cash Flow from Investing Activities | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr | ₹-164 Cr |
Cash Flow from Financing Activities | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr | ₹-301 Cr |
Net Cash Inflow / Outflow | ₹221 Cr | ₹134 Cr | ₹-172 Cr | ₹264 Cr | ₹36 Cr |
Opening Cash & Cash Equivalents | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr | ₹-609 Cr | ₹-641 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | ₹214 Cr | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹-2.00 Cr | ₹-0.13 Cr | ₹0.19 Cr | ₹-4.62 Cr | ₹-4.17 Cr |
Closing Cash & Cash Equivalent | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr | ₹-609 Cr |
Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EMCURE PHARMACEUTICALS | ₹24,570.6 Cr | 4.3% | -5.9% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
EMCURE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EMCURE PHARMACEUTICALS | 4.3% |
-5.9% |
|
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses